A detailed history of Principal Securities, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Principal Securities, Inc. holds 28,757 shares of NVS stock, worth $3.03 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
28,757
Previous 26,144 9.99%
Holding current value
$3.03 Million
Previous $3.01 Billion 6.94%
% of portfolio
0.06%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$96.78 - $117.18 $252,886 - $306,191
2,613 Added 9.99%
28,757 $2.8 Billion
Q3 2024

Oct 28, 2024

BUY
$106.13 - $120.89 $440,757 - $502,056
4,153 Added 18.88%
26,144 $3.01 Billion
Q2 2024

Jul 31, 2024

BUY
$92.57 - $107.37 $521,169 - $604,493
5,630 Added 34.41%
21,991 $2.34 Billion
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $360,882 - $410,884
-3,788 Reduced 18.8%
16,361 $1.58 Billion
Q4 2023

Feb 07, 2024

BUY
$92.27 - $101.54 $1.86 Million - $2.05 Million
20,149 New
20,149 $2.03 Billion

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.